SEC 13F Intelligence

Dekabank Deutsche Girozentrale / VRTX

Dekabank Deutsche Girozentrale’s Vertex Pharmaceuticals Inc Position

Does Dekabank Deutsche Girozentrale own Vertex Pharmaceuticals Inc (VRTX)? Yes — 506.5K shares worth $230M (+0.38% of its 13F portfolio) as of Q1 2026.

Position Value
$230M
Q1 2026
Shares
506.5K
% of Portfolio
+0.38%
Quarters Held
28
currently held

Position History VRTX

Reported value by quarter
Q1 ’19: $20MQ1 ’19Q2 ’19: $67MQ3 ’19: $39MQ4 ’19: $14MQ1 ’20: $14MQ1 ’20Q2 ’20: $18MQ3 ’20: $68MQ1 ’21: $64MQ2 ’21: $66MQ2 ’21Q3 ’21: $63MQ4 ’21: $76MQ1 ’22: $124MQ2 ’22: $131MQ2 ’22Q3 ’22: $123MQ4 ’22: $125MQ1 ’23: $141MQ2 ’23: $163MQ2 ’23Q3 ’23: $166MQ4 ’23: $206MQ1 ’24: $204MQ2 ’24: $237MQ2 ’24Q3 ’24: $233MQ4 ’24: $205MQ1 ’25: $239MQ2 ’25: $223MQ2 ’25Q3 ’25: $200MQ4 ’25: $220MQ1 ’26: $230Mfilingsflow.com
QuarterSharesValue% of Portfolio
Q1 2026506.5K$230M+0.38%
Q4 2025506.5K$220M+0.38%
Q3 2025506.5K$200M+0.34%
Q2 2025506.5K$223M+0.40%
Q1 2025491.1K$239M+0.47%
Q4 2024506.5K$205M+0.38%
Q3 2024506.5K$233M+0.43%
Q2 2024501.5K$237M+0.43%
Q1 2024491.1K$204M+0.38%
Q4 2023504.0K$206M+0.42%
Q3 2023470.1K$166M+0.38%
Q2 2023466.0K$163M+0.37%
Q1 2023452.4K$141M+0.35%
Q4 2022433.6K$125M+0.33%
Q3 2022422.7K$123M+0.36%
Q2 2022472.5K$131M+0.38%
Q1 2022480.1K$124M+0.30%
Q4 2021338.3K$76M+0.18%
Q3 2021344.7K$63M+0.18%
Q2 2021335.9K$66M+0.19%
Q1 2021297.7K$64M+0.21%
Q3 2020255.4K$68M+0.30%
Q2 202062.2K$18M+0.11%
Q1 202058.4K$14M+0.10%
Q4 201961.3K$14M+0.08%
Q3 2019233.0K$39M+0.24%
Q2 2019374.2K$67M+0.34%
Q1 2019106.7K$20M+0.12%

Common-stock position only; options are excluded. Quarters where the fund filed no 13F or reported no position are absent. See Dekabank Deutsche Girozentrale’s full portfolio or all institutional holders of VRTX.